Validation Study of a New Digital Treatment Test

Braingaze60 enrolled

Overview

Oculomotor behavior and cognitive processing of visual information are intimately connected. AD patients show ocular movement problems. Oculomotor deficits are broad consisting mainly of different saccade metrics, altered pupil responses. and smaller and irregular eye vergence movements. Here we test an interactive eye-tracking game to improve eye motion control and thereby training cognitive behavior

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Alzheimer Disease MCI

Interventions

BGaze therapy AlzheimerOTHER

BGaze Therapy is an interactive eye tracking game

Eligibility

Sex: ALLMin age: 50 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1\) Clinical diagnosis of MCI or AD Exclusion Criteria: 1. Severe cognitive deterioration 2. History of neurological disease with clinically relevant impact on cognition 3. Severe psychiatric disorder 4. Incidental structural brain findings with impact on cognitive impairment 5. Presence of relevant visual problems

Locations (1)

Braingaze

Mataró, Barcelona, Spain

RECRUITING

Outcomes

Primary Outcomes

MoCA

Measure changes in MoCA

Time frame: immediately after the intervention

MMSE

Measure changes in MMSE

Time frame: immediately after the intervention

Secondary Outcomes

CANTAB

Measure changes in CANTAB tests

Time frame: immediately after the intervention

Central Contacts

Hans Super

CONTACT

0034931696572 hans@braingaze.eu

Laszlo Bax

CONTACT

0034931696572 Laszlo@braingaze.eu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.